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Résumé en
anglais
Pseudoxanthoma elasticum (PXE) is a heritable disease characterized by calcified
elastic fibers in cutaneous, ocular, and vascular tissues. PXE is caused by mutations
in ABCC6, which encodes a protein of the ATP-driven organic anion transporter
family. The inability of this transporter to secrete its substrate into the circulation is
the likely cause of PXE. Vitamin K plays a role in the regulation of mineralization
processes as a co-factor in the carboxylation of calcification inhibitors such as
Matrix Gla Protein (MGP). Vitamin K precursor or a conjugated form has been
proposed as potential substrate(s) for ABCC6. We investigated whether an enriched
diet of vitamin K1 or vitamin K2 (MK4) could stop or slow the disease progression in
Abcc6 (-/-) mice. Abcc6 (-/-) mice were placed on a diet of either vitamin K1 or MK4
at 5 or 100 mg/kg at prenatal, 3 weeks or 3 months of age. Disease progression was
quantified by measuring the calcium content of one side of the mouse muzzle skin
and histological staining for calcium of the opposing side. Raising the vitamin K1 or
MK4 content of the diet increased the concentration of circulating MK4 in the
serum. However, this increase did not significantly affect the MGP carboxylation
status or reduce its abnormal abundance, the total calcium content or the pathologic
calcification in the whiskers of the 3 treatment groups compared to controls. Our
findings showed that raising the dietary intake of vitamin K1 or MK4 was not
beneficial in the treatment of PXE and suggested that the availability of vitamin K
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